| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.3 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | -0.13 | 0.3 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.055 | 0.3 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |